The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...
Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according ...
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...
Type 2 diabetics may have a shot at significantly lowering their risk of Alzheimer’s disease if they take Ozempic instead of ...
The company now expects 2024 profit in the range of $6.55 to $6.75 per share, compared with its previous profit per share forecast of $6.35 to $6.65. The Pennsylvania-based firm has been anticipating ...